Research & development
split-image
first
Research & Development
How can life sciences leaders conquer R&D complexity to bring therapies to patients faster? Today’s teams face competing demands: innovate faster, construct portfolios for long-term growth, accelerate clinical trials and turn generative AI and new technology into real, repeatable value.
true
white
Consulting and technology Solutions
true
Let’s connect
primary
Second Button CTA Text
secondary
default
What we do
ZS lends R&D strategy experts, domain depth, advanced analytics, emerging technologies and modular products to help life sciences companies move from molecule to market. From early discovery to clinical development, medical affairs and evidence generation, ZS accelerates digital transformation in R&D with smarter solutions, integrated planning and fit-for-purpose platforms. The result: innovative therapies reach patients around the world faster—and patients’ voices shape what you build next.
center
white
Eyebrow Text
Button CTA Text
primary
default
image
ZS discovery
h3
research and discovery
Accelerate breakthrough science and increase probability of success by applying bioinformatics, advanced molecular and data science and in silico methodologies.
Let’s go
Clinical development
h3
clinical development
Fast-track trial design to delivery with AI, digital twins and real-time analytics—anchored in patient needs and insights.
Let’s go
Medical affairs & evidence
h3
medical affairs and evidence
Strengthen your role as a trusted healthcare connector with scalable scientific insights combining domain expertise, built-in compliance and data, analytics and technology.
Let’s go
default
Differentiators that move the needle
See how ZS drives innovation and efficiency in life sciences research and development.
ZS combines scientific talent, deep domain expertise, R&D data and analytics solutions, generative AI innovation, and flexible digital platforms to help pharma and biotech organizations modernize how research happens. Through close collaboration with R&D leaders, we deliver clinical research solutions and digital transformation in R&D that accelerate discovery, development and medical impact.
left
white
Eyebrow Text
Button CTA Text
primary
default
light-accordion-a
single
Scientific expertise that powers credible R&D innovation
h3
ZS’s scientists, physicians and computational biologists bring hands-on lab and data experience to every engagement. Our PhDs and MDs power life sciences innovation by applying deep scientific understanding to build credible, reproducible and regulatory-grade clinical R&D solutions that advance the science of drug development.
true
Call to action
Deep domain and regulatory expertise across the R&D continuum
h3
ZS’s experience spans the full life sciences research and development value chain, from early discovery to evidence generation. Our drug development consulting teams understand the business, data and regulatory realities of pharma R&D, helping clients reduce cycle times, raise success rates and get more therapies to patients faster.
true
Call to action
R&D data and analytics solutions that drive confident decisions
h3
ZS helps organizations master complex R&D data ecosystems. By connecting research, clinical trial solutions and real-world evidence, we create analytics solutions that improve predictability, automate workflows and strengthen decision-making across the life sciences research and development continuum.
true
Call to action
Generative AI and emerging tech for transforming R&D
h3
ZS is leading a wave of digital transformation in R&D through advanced AI and computational modeling. Recognized as a leader in IDC MarketScape’s Worldwide Life Sciences R&D AI (including GenAI) in Clinical Trials 2025 Vendor Assessment, we embed generative AI, digital twins and in silico techniques into discovery, clinical and evidence workflows to simulate experiments, predict outcomes and accelerate scientific decision-making. These innovations reduce cycle time, improve accuracy and unlock new frontiers of pharma R&D productivity.
true
Call to action
Scaled impact with flexible platforms and products
h3
Siloed tools and rigid tech stacks are the enemy of scale. ZS platforms and solutions such as ZS Discovery, RBQM360 and ZAIDYN Clinical accelerate digital transformation in R&D through modular design and seamless integration with systems like Veeva, Oracle and SAP. The result: faster rollouts, greater agility and outsized impact.
true
Call to action
Delivering more therapies with cross-functional, cross-sector expertise
h3
Navigating today’s complexifying R&D landscape demands drug development consulting expertise spanning strategy, tech and domain fluency. We combine applied scientists, clinical development experts, solution architects and seasoned trial experts who deeply understand patient experiences and pharma R&D.
true
Call to action
Collaborating to shape the future of R&D
h3
ZS partners with clients, advisors and industry leaders to challenge the status quo, share insights and co-create innovative solutions that advance life sciences research and development.
true
Call to action
layout-a
fixedList
default
Explore our products and capabilities
left
white
Eyebrow Text
Button CTA Text
primary
default
image
Strategy & Transformation
h3
Strategy & Transformation
Translate the potential of your strategies into long-term value and growth for your business and drive transformational change across your enterprise.
Let’s go
AI & Analytics
h3
AI & Analytics
Reimagine enterprise analytics with AI solutions across research and development, brand strategy, pricing, marketing, sales, customer engagement, manufacturing and supply chain.
Let’s go
Data, Digital & Technology
h3
Data, Digital & Technology
Maximize the value of data. From scalable data management, modern governance and AI-ready architectures, ZS helps you turn information into clarity and confidence.
Let’s go
ZAIDYN medical
h3
zaidyn medical
Transform scientific engagement and evidence generation with AI driven insight discovery, opinion leader intelligence, and real-world data analytics, helping medical teams accelerate evidence creation and amplify scientific impact.
Learn more
ZAIDYN patient engagement
h3
patient experience bank
Connect patients, providers, and programs with personalized, AI-driven intelligence. Deliver timely interventions and data-driven insights that help you improve adherence, enhance engagement and achieve better real-world outcomes.
Learn more
light-accordion-a
single
How can pharma R&D teams modernize their technology infrastructure?
h3
With life sciences research and development organizations under increasing pressure to evolve, fragmented data, legacy systems and manual processes are blocking progress. ZS helps R&D teams accelerate transformation through modular, AI-powered solutions, cloud-native platforms, digital workflows and real-time data integration.
false
Call to action
How does ZS enable digital transformation in R&D?
h3
ZS helps R&D teams streamline operations and eliminate silos with modular platforms, AI, automation and real-time data flow. From digital protocols to insight generation, we build scalable tech that drives faster trials and long-term portfolio growth.
false
Call to action
What emerging technologies will generate the most value in pharma R&D?
h3
Technologies such as generative AI, in silico trials, digital twins and quantum computing are redefining clinical R&D solutions. ZS enables digital transformation in R&D that improves trial design, reduces timelines and boosts life sciences innovation.
false
Call to action
How does ZS help pharma organizations align R&D strategy with measurable outcomes?
h3
ZS helps R&D leaders make smarter investment decisions, reduce risk and move with confidence. We work with you to define strategy up front, align teams early and focus on what drives impact—so your pipeline delivers more, faster.
false
Call to action
Does ZS have expertise in rare disease and oncology?
h3
Yes. ZS supports rare‑disease strategies including patient‑journey mapping and diagnosis acceleration. We also bring advanced analytics and consulting capabilities to oncology across tumor types and launch planning.
“80% of drug launches in oncology in the last five years” and more than 100 client engagements across 35+ tumor types.
false
Call to action
How can I modernize my medical affairs function?
h3
Legacy medical affairs programs are too often reactive and disconnected from the broader R&D organization. ZS supports medical affairs organizations from strategy to implementation with AI-enabled insights, modular platforms, cross-functional integration and better measurement of impact on patient outcomes.
false
Call to action
h2
manual